Literature DB >> 31301687

Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII-deficient mice.

Esther J Cooke1,2, Tine Wyseure2, Jenny Y Zhou1, Srila Gopal1, Chanond A Nasamran3, Kathleen M Fisch3, Tina Manon-Jensen4, Morten A Karsdal4, Laurent O Mosnier2, Annette von Drygalski1,2.   

Abstract

BACKGROUND: Vascular remodeling associated with hemophilic arthropathy (HA) may contribute to bleed propagation, but the mechanisms remain poorly understood.
OBJECTIVES: To explore molecular mechanisms of HA and the effects of hemostasis correction on synovial vascular remodeling after joint injury in hypocoagulable mice.
METHODS: Factor VIII (FVIII)-deficient mice +/- FVIII treatment and hypocoagulable wild-type mice (Hypo BALB/c) were subjected to subpatellar puncture. Hypo BALB/c mice were treated with warfarin and anti-FVIII before injury, after which warfarin was continued for 2 weeks or reversed +/- continuous anti-FVIII until harvest. Synovial vascularity was analyzed at baseline and 2 to 4 weeks post injury by histology, musculoskeletal ultrasound with power Doppler (microvascular flow), and Evans blue extravasation (vascular permeability). Synovial gene expression and systemic markers of vascular collagen turnover were studied in FVIII-deficient mice by RNA sequencing and enzyme-linked immunosorbent assay.
RESULTS: Vascular changes occurred in FVIII-deficient and Hypo BALB/c mice after injury with minimal effect of hemostasis correction. Increased vascular permeability was only significant in FVIII-deficient mice, who exhibited more pronounced vascular remodeling than Hypo BALB/c mice despite similar bleed volumes. FVIII-deficient mice exhibited a strong transcriptional response in synovium that was only partially affected by FVIII treatment and involved genes relating to angiogenesis and extracellular matrix remodeling, with vascular collagen turnover markers detected systemically.
CONCLUSIONS: Intact hemostasis at the time of hemarthrosis and during healing are both critical to prevent vascular remodeling, which appears worse with severe and prolonged FVIII deficiency. Unbiased RNA sequencing revealed potential targets for intervention and biomarker development to improve management of HA.
© 2019 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  factor VIII; hemarthrosis; hemostasis; sequence analysis, RNA; vascular remodeling

Year:  2019        PMID: 31301687      PMCID: PMC6824926          DOI: 10.1111/jth.14567

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  43 in total

1.  Ultrasound detects joint damage and bleeding in haemophilic arthropathy: a proposal of a score.

Authors:  D Melchiorre; S Linari; M Innocenti; I Biscoglio; M Toigo; M M Cerinic; M Morfini
Journal:  Haemophilia       Date:  2010-11-11       Impact factor: 4.287

2.  Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization.

Authors:  Eveline P Mauser-Bunschoten; Jacco A C Zijl; Willem Mali; A Cees van Rinsum; H Marijke van den Berg; Goris Roosendaal
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

3.  A novel signaling pathway impact analysis.

Authors:  Adi Laurentiu Tarca; Sorin Draghici; Purvesh Khatri; Sonia S Hassan; Pooja Mittal; Jung-Sun Kim; Chong Jai Kim; Juan Pedro Kusanovic; Roberto Romero
Journal:  Bioinformatics       Date:  2008-11-05       Impact factor: 6.937

4.  IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia.

Authors:  N Narkbunnam; J Sun; G Hu; F-C Lin; T A Bateman; M Mihara; P E Monahan
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

5.  Neoangiogenesis contributes to the development of hemophilic synovitis.

Authors:  Suchitra S Acharya; Rosandra N Kaplan; Dan Macdonald; Oluwa T Fabiyi; Donna DiMichele; David Lyden
Journal:  Blood       Date:  2010-12-16       Impact factor: 22.113

6.  Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis.

Authors:  Junjiang Sun; Baolai Hua; Eric W Livingston; Sarah Taves; Peter B Johansen; Maureane Hoffman; Mirella Ezban; Dougald M Monroe; Ted A Bateman; Paul E Monahan
Journal:  Blood       Date:  2016-12-30       Impact factor: 22.113

7.  Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant.

Authors:  A von Drygalski; T J Cramer; V Bhat; J H Griffin; A J Gale; L O Mosnier
Journal:  J Thromb Haemost       Date:  2014       Impact factor: 5.824

Review 8.  Advances and challenges in hemophilic arthropathy.

Authors:  Tine Wyseure; Laurent O Mosnier; Annette von Drygalski
Journal:  Semin Hematol       Date:  2015-10-26       Impact factor: 3.851

9.  Haemophilia in Spain.

Authors:  J A Aznar; F Lucía; L Abad-Franch; V Jiménez-Yuste; R Pérez; J Batlle; I Balda; R Parra; V R Cortina
Journal:  Haemophilia       Date:  2009-05       Impact factor: 4.287

10.  Angiogenesis is increased in advanced haemophilic joint disease and characterised by normal pericyte coverage.

Authors:  Eva Zetterberg; Jan Palmblad; Rickard Wallensten; Massimo Morfini; Daniela Melchiorre; Margareta Holmström
Journal:  Eur J Haematol       Date:  2013-11-25       Impact factor: 2.997

View more
  4 in total

1.  Bleeding with iron deposition and vascular remodelling in subchondral cysts: A newly discovered feature unique to haemophilic arthropathy.

Authors:  Jenny Y Zhou; Jonathan H Wong; Zachary T Berman; Alecio F Lombardi; Eric Y Chang; Annette von Drygalski
Journal:  Haemophilia       Date:  2021-09-19       Impact factor: 4.263

2.  EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.

Authors:  Jhansi Magisetty; Usha R Pendurthi; Charles T Esmon; L Vijaya Mohan Rao
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

Review 3.  The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.

Authors:  Juan A De Pablo-Moreno; Luis Javier Serrano; Luis Revuelta; María José Sánchez; Antonio Liras
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

Review 4.  The Progression of Hemophilic Arthropathy: The Role of Biomarkers.

Authors:  Gianluigi Pasta; Salvatore Annunziata; Alberto Polizzi; Laura Caliogna; Eugenio Jannelli; Alessandro Minen; Mario Mosconi; Francesco Benazzo; Matteo Nicola Dario Di Minno
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.